usually sporadic and associated with the involvement of other cranial nerves, commonly the abducens nerve in addition to orofacial and limb malformations as well as defects of the musculoskeletal system [MacKinnon et al., 2014] . De novo mutations in 2 genes, PLXND1 and REV3L , were recently found to be associated with MBS [Tomas-Roca et al., 2015] . Congenital facial palsy (CFP) is classified as acquired or developmental, unilateral or bilateral, and complete (palsy) or incomplete (paresis). A careful diagnostic work-up and differential diagnosis are important in order to determine the aetiology, as the prognosis and the therapeutic approach differs, depending on the underlying pathophysiology [Terzis and Anesti, 2011; Ciorba et al., 2015] . Based on previous studies, genetic heterogeneity and different modes of inheritance have been suggested for this disorder. Two genetic loci, termed HCFP1 (MIM %601471) and HCFP2 (MIM %604185), have been defined in 2 families with autosomal dominant HCFP, but neither gene has been identified [Kremer et al., 1996; Verzijl et al., 1999; Michielse et al., 2006] . The only known autosomal recessive HCFP (HCFP3) is caused by biallelic mutations in HOXB1 (MIM %142968) in chr17q21.32 (MIM 614744). Recently, 4 mutations (3 missense and 1 nonsense) in the HOXB1 gene have been identified in 12 patients from 5 unrelated consanguineous families with HCFP3 ( Fig. 1 ) [Webb et al., 2012; Uyguner et al., 2015; Vogel et al., 2016; Sahin et al., 2017] . HOXB1 is a homeobox transcription factor which is part of a developmental regulatory system expressed in the embryological spinal cord and hindbrain and is essential for rhombomere 4 (r4) development [Webb et al., 2012] .
This study presents an Iranian extended consanguineous family in which 5 members suffer from HCFP. Genetic screening of the only currently known candidate gene for the condition revealed a novel homozygous truncating mutation in HOXB1 .
Patients and Methods
The patient medical records were reviewed and clinical examinations including opthalmological and auditory exams were performed. A detailed family history was collected and a pedigree was drawn. Blood samples from the 5 affected members of the family as well as their parents and unaffected siblings were obtained for genetic testing.
Genetic Study
Genomic DNA was extracted from blood samples using Qiagen Gentra Puregene DNA isolation kits (Qiagen, Valencia, CA, USA). Mutation analysis was performed by PCR amplifying all exons and exon-intron boundaries of the HOXB1 gene, using 2 pairs of primers. All the resulting amplicons were Sanger sequenced. Sequencing results from affected and unaffected individuals were analysed using FinchTV Software. Primer sequences and screening conditions are available upon request.
Results
We investigated a large Iranian consanguineous kindred including 5 affected individuals ( Fig. 1 A; V-2, 2 years old; V-5, 9 years old; V-7, 11 years old; VI-3, 24 years old, and VI-18, 25 years old) who were initially suspected to have MBS. The initial clinical presentation was congenital non-progressive mask-like faces and bilateral facial palsy. Due to facial muscle weakness and paresis, these individuals could not smile, frown, or cry. They had severe feeding difficulty and inadequate suckling of milk during infancy; however, they could discriminate tastes. Salivation and lacrimation were both intact. Two patients also had congenital mixed, sensorineural and conductive bilateral hearing loss and were using hearing aids. Their hearing impairment was non-progressive and moderate to severe. Additional clinical features of the patients were facial dysmorphism, including a smooth philtrum, lowset ears, external ear malformation (in 3 patients), midface retrusion, upturned nasal tip, and tooth abnormalities ( Fig. 1 C) . Brain CT scans performed on 2 affected individuals did not identify any abnormality. The karyotype of one patient was examined and found to be normal. All 5 affected individuals showed typical signs of HCFP with full eye motility and no eye movement abnormalities. Based on the extended 3-generation pedigree, with the presence of consanguinity and healthy parents, an autosomal recessive mode of inheritance was suggested for the disease.
The disease phenotype and family history was not consistent with a diagnosis of MBS; we therefore screened the only known autosomal recessive HCFP-causing gene HOXB1 . Direct sequencing of the HOXB1 gene identified a novel 7-bp deletion -(NM_002144.3, hg19) chr17: g.46607965_46607971delAGAGGGT;
c.296_302del; Y99Wfs * 20 -present in a homozygote state in the first coding exon ( Fig. 1 B) . The mutation resulted in a frameshift predicted to cause premature termination of the protein. This variant has not been reported in a heterozygous or homozygous state in publicly available databases, including dbSNP (build 138), the Exome Sequencing Project databases (http://evs.gs.washington.edu/ EVS/), gnomeAD browser (http://gnomad.broadinsti-tute.org), the 1000 Genome Project (http://1000genomes. org/), The Greater Middle East Variome project (http:// igm.ucsd.edu/gme/index.php) or our in-house database of 500 Iranian Whole Exome Sequencing. The mutation completely co-segregates with the disease phenotype in this large family ( Fig. 1 A) . Clinical features of the affected family members are summarised in Table 1 and compared to previously reported patients with HOXB1 mutations.
Discussion
Until now, there are 17 HCFP patients reported worldwide, including 5 patients from this study, in whom causative mutations have been identified ( Fig. 2 ) [Webb et al., 2012; Uyguner et al., 2015; Vogel et al., 2016; Sahin et al., 2017] . Our findings consolidate the role of HOXB1 in autosomal recessive HCFP and expand the mutational and phenotypic spectrum of HOXB1 variations in causing CCDD. The mutation we report here would likely result in a null mutation due to nonsense-mediated decay of the [Webb et al., 2012] . Our data strongly support the conclusion that the key overlapping clinical features -facial weakness and dysmorphia -result from the loss of HOXB1 function.
Understanding the association of CFP with concomitant esotropia is important in achieving a differential diagnosis of HCFP and MBS. HOXB1 mutations have not been found in patients with classic MBS in this study or previous reports, suggesting that it may be a useful diagnostic marker [Ciorba et al., 2015] . Our data also demonstrate that further analysis of the regulation and function of HOXB1 will help elucidate CCDD pathology.
The loss-of-function mutation in 5 affected members of the current report exhibits a similar clinical presentation to that observed in previous patients with HOXB1 mutations. Moreover, there is no clear genotype-phenotype correlation with regards to the type of mutations, their location in the protein, and severity of the pheno- type. However, as seen in Moroccan patients with a lossof-function mutation, 3 of these Iranian patients showed external ear malformations, which were not observed in the other 8 reported patients with missense mutations or in the HOXB1 -deficient mouse model [Webb et al., 2012; Uyguner et al., 2015; Vogel et al., 2016; Sahin et al., 2017] . Further cases of HOXB1-related HCFP would be necessary before we can confidently establish an association between the genotype and the phenotype of external ear malformation in this rare disease. External ear malformation is not an uncommon occurrence in MBS patients [Suvarna et al., 2006] . Additionally, a combined phenotype of CFP and external ear anomalies has been reported in an unknown autosomal dominant syndrome characterised by conductive deafness due to stapedial anomalies, external ear malformations, and CFP [Sellars and Beighton, 1983] . We identified a novel homozygous truncating mutation in HOXB1 in a consanguineous kindred with HCFP, which is broadly similar to the clinical phenotype of patients who were previously described. The mutation identified in this family is the first indel described in HOXB1 so far. It must be emphasised that in individuals with CFP, hearing loss, dysmorphic facial features, and full eye motility, HOXB1 mutation screening should be considered to help with an accurate diagnosis.
